FDA Investigator Mark Gray
Mark Gray has inspections in 1 countries as of 16 Oct 2023. Mark Gray has collaborated with a combined 1153 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alexandra B Pitkin,
Angela Shepas,
Anthony E Guzman,
Bonnie I Needleman,
Bowman,
Brandon R Boone,
Burnsb,
Carey A Watson,
Carr Sharpe,
Cathryn M Groehnert,
Christopher J Stannard,
Darrin E Davis,
Davis,
Debbie K Giang,
Debra J Fracassa,
Denise H Howell,
Dennis N Hoang,
Diane Cvan Leeuwen,
Eileen T Dupont,
Erik D Sandvig,
Fe Q Reyes,
Francisco,
Gabriel Craig,
Geraldine M Peregrin,
Gordon Chu,
Hai T Truong,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Irma D Padilla,
Jake T Lane,
James P Stallings,
Jeannie Pradyanata,
Jeff M Uriarte,
Jinnie Kokiatkulkij,
John A Liu,
John R Myung,
Joseph Brady,
Joseph C Francisco,
Joseph H Lam,
Judy C Nepsa,
Kai Wang,
Katherine P Tran,
Kevin Lee,
Kevin T Gerrity,
Kimberly M Lichter,
Lilly O Barton,
Mark C Saale,
Natalie J Ayoub,
Natalie J Reese,
Nianna C Burns,
Nicholas J Lahey,
Patrick R Dimapindan,
Randal Anderson,
Richard W Tubb,
Rochelle A Rolnik,
Saied A Asbagh,
Sandersk,
Sara Jdent Acosta,
Sarah A Hassas,
Sean P Desbrow,
State Agency,
Sundy Ven,
Sunita Vij,
Tara L Stockton,
Thanh B Tran,
William J Leonard,
Yen Tso Kuo,
Yolanda D Mitchell Lee,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zenja D Woodley
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more